International Journal of Cancer

High-fat diet promotes prostate cancer growth through histamine signaling.  151:623-636. 2022

Comments on “Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns”.  149:1398. 2021

Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer.  149:909-916. 2021

Impact of screening on cervical cancer incidence: A population-based case–control study in the United States.  147:887-896. 2020

The 6-minute walk test is a good predictor of cardiorespiratory fitness in childhood cancer survivors when access to comprehensive testing is limited.  147:847-855. 2020

Neighborhood effect and obesity in adult survivors of pediatric cancer: A report from the St. Jude lifetime cohort study.  147:338-349. 2020

Epidemiological evidence that common HPV types may be common because of their ability to evade immune surveillance: Results from the Women's Interagency HIV study.  146:3320-3328. 2020

Identification of novel epithelial ovarian cancer loci in women of African ancestry.  146:2987-2998. 2020

Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics.  146:2784-2796. 2020

Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology—Retrospective insights from ATHENA.  146:2599-2607. 2020

Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.  146:739-748. 2020

A note on competing risks in analyses of cancer-specific mortality.  145:1704-1705. 2019

Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance.  145:474-483. 2019

Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: results from a prospective cohort study.  143:1105-1113. 2018

Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis.  141:1091-1109. 2017

Dietary inflammatory index and risk of epithelial ovarian cancer in African American women.  140:535-543. 2017

A prospective study of dietary patterns and cancer mortality among Blacks and Whites in the REGARDS cohort.  139:2221-2231. 2016

Obesity, weight gain, and ovarian cancer risk in African American women.  139:593-600. 2016

Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination.  139:491-500. 2016

Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen.  139:628-638. 2016

The Notch pathway in colorectal cancer.  138:1835-1842. 2016

Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study.  137:930-939. 2015

Nonclassical HEDGEHOG-GLI signaling and its clinical implications.  135:1-6. 2014

Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer.  134:948-953. 2014

Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis.  134:717-730. 2014

A candidate gene approach for virally induced cancer with application to HIV-related Kaposi's sarcoma.  134:397-404. 2014

Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo.  132:1201-1212. 2013

Host-derived osteopontin maintains an acute inflammatory response to suppress early progression of extrinsic cancer cells.  131:322-333. 2012

Dickkopf1: A tumor suppressor or metastasis promoter?.  130:1477-1483. 2012

Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.  130:1695-1705. 2012

D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD.  130:1071-1081. 2012

Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice.  130:765-774. 2012

CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.  127:2020-2030. 2010

Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer.  126:1513-1520. 2010

Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.  125:2704-2710. 2009

Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.  125:2288-2295. 2009

Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.  125:2441-2449. 2009

Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression.  125:1778-1785. 2009

Nmi (N-Myc interactor) inhibits Wnt/β-catenin signaling and retards tumor growth.  125:556-564. 2009

Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.  125:286-296. 2009

Induction of myeloid-derived suppressor cells by tumor exosomes.  124:2621-2633. 2009

Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.  124:1470-1477. 2009

Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.  123:2254-2259. 2008

Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin in pigmented fruits and vegetables.  123:1508-1515. 2008

Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy.  123:1448-1456. 2008

Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1.  123:526-534. 2008

Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras.  123:100-107. 2008

Common variants in genes that mediate immunity and risk of multiple myeloma.  120:2715-2722. 2007

Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.  120:935-941. 2007

Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice.  118:2639-2643. 2006

Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer.  118:2220-2231. 2006

Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition.  118:1041-1050. 2006

Lack of guanylyl cyclase C, the receptor for Escherichia coli heat-stable enterotoxin, results in reduced polyp formation and increased apoptosis in the multiple intestinal neoplasia (Min) mouse model.  116:500-505. 2005

Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate.  115:11-18. 2005

IL-1β induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3′ untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR.  113:911-919. 2005

Women with polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MS) are less likely to have cervical intraepithelial neoplasia (CIN) 2 or 3.  113:991-997. 2005

Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-κB pathways and inhibits skin tumorigenesis in CD-1 mice.  113:423-433. 2005

Antitumor activity of the intratumoral injection of fowlpox vectors expressing a triad of costimulatory molecules and granulocyte/macrophage colony stimulating factor in mesothelioma.  113:406-414. 2005

Association of thymidylate synthase polymorphisms with gastric cancer susceptibility.  112:1010-1014. 2004

Some remarks on the somatic expression of sperm protein 17 [1] (multiple letters).  111:972-973. 2004

Breast cancer metastatic potential: Correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells.  111:693-697. 2004

Absence of KLF6 gene mutations in human astrocytic tumors and cell lines [2].  111:642-643. 2004

Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer.  111:303-309. 2004

Expression of sperm protein 17 (Sp17) in ovarian cancer.  108:805-811. 2004

Inhibition of prostate cancer metastatic colonization by ∼4.2 Mb of human chromosome 12.  108:15-22. 2004

BXD recombinant inbred mice represent a novel T cell-mediated immune response tumor model.  101:270-279. 2002

DNA topoisomerase IIα predicts progression-free and overall survival in pediatric malignant non-brainstem gliomas.  99:817-820. 2002

Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women.  98:118-127. 2002

Molecular staging of colorectal cancer in African-American and caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 and p27^kip-1.  97:403-409. 2002

Cu/Zn superoxide dismutase plays a role in angiogenesis.  97:34-41. 2002

Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1)..  97:15-20. 2002

Restoration of endogenous wild-type p53 activity in a glioblastoma cell line with intrinsic temperature-sensitive p53 induces growth arrest but not apoptosis.  94:35-43. 2001

Invasion and metastasis of a mammary tumor involves TGF-β signaling.  91:76-82. 2001

BC1-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.  89:423-430. 2000

Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas..  89:423-430. 2000

A human melanoma metastasis-suppressor locus maps to 6q16.3-q23.  86:524-528. 2000

Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma.  82:424-429. 1999

Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses.  79:640-644. 1998

Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.  76:797-800. 1998

Priming in the brain, an immunologically privileged organ, elicits anti- tumor immunity.  75:266-276. 1998

"Turcot's syndrome": phenotype of brain tumors, survival and mode of inheritance..  75:162-164. 1998

Anthropometric indices in relation to mammographic patterns among peri- menopausal women.  73:323-326. 1997

Effects of an inducible anti-sense c-myc gene transfer in a drug- resistant human small-cell-lung-carcinoma cell line.  73:544-550. 1997

Effects of an inducible anti-sense c-myc gene transfer in a drug-resistant human small-cell-lung-carcinoma cell line..  73:544-550. 1997

Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of HuD in the variant phenotype..  74:378-382. 1997

Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.  74:346-358. 1997

Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display.  71:1035-1044. 1997

Identification of nude mice in tumorigenicity assays..  71:310. 1997

Elevated serum levels of p105(erbB-2) in patients with advanced-stage prostatic adenocarcinoma.  69:398-402. 1996

CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus.  69:254-258. 1996

CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus..  69:254-258. 1996

Human astrocytomas and glioblastomas express monocyte chemoattractant protein‐1 (MCP‐1) in vivo and in vitro.  58:240-247. 1994

Differential expression of the CD44 molecule in human brain tumours.  50:572-577. 1992

Effect of smoking on folate levels in buccal mucosal cells.  52:566-569. 1992

Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line.  47:227-237. 1991

Establishment of an EBV‐positive lymphoblastoid cell line that grows as a lymphoma in nude mice and expresses membrane CD2 molecules.  45:299-307. 1990

Inhibition of growth and squamous‐cell differentiation markers in cultured human head and neck squamous carcinoma cells by β‐all‐trans retinoic acid.  45:195-202. 1990

An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensin.  43:215-219. 1989

Use of the membrane invasion culture system (mics) as a screen for anti‐invasive agents.  43:449-457. 1989

The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762nf mammary adenocarcinoma cells.  42:748-759. 1988

Regulation of mopc 104e by T cells and growth factors induced by C. Parvum stimulation.  33:845-850. 1984

Surgical adjuvant chemotherapy of metastatic murine osteosarcoma.  25:393-397. 1980

Rauscher leukemia as a model for studies of marrow transplantation therapy: Results using syngeneic, allogeneic and hybrid donors.  24:438-444. 1979

Capillary tube leukocyte adherence inhibition: An assay for cell‐mediated immunity in cancer patients.  17:338-341. 1976

Detection of human tumor‐associated antigens by the leukocyte migration in agarose assay.  18:161-167. 1976

Inhibition of leukocyte migration in agarose by KC1 extracts of a human melanoma cell line grown in serum‐free medium.  16:1035-1041. 1975